Homogeneous MGMT immunoreactivity correlates with an unmethylated MGMT promoter status in brain metastases of various solid tumors. [electronic resource]
Producer: 20090615Description: e4775 p. digitalISSN:- 1932-6203
- Alkylating Agents -- therapeutic use
- Brain Neoplasms -- diagnosis
- Breast Neoplasms -- pathology
- DNA Methylation
- DNA Modification Methylases -- analysis
- DNA Repair Enzymes -- analysis
- Dacarbazine -- analogs & derivatives
- Immunohistochemistry
- Kidney Neoplasms -- pathology
- Lung Neoplasms -- pathology
- Melanoma -- pathology
- Polymerase Chain Reaction
- Promoter Regions, Genetic
- Temozolomide
- Tumor Suppressor Proteins -- analysis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.